Ann: Chilean Cultivation Licence Secured for Second Crop, page-13

Ive been holding AC8 since the IPO. I cant help noticing that CAN, THC and CPH are all more rev generating focused which in the end justifies each of their market caps. great anns by all three of them in the recent few weeks... I think AC8 has to really start focusing on securing even a potential rev streams for 2018 otherwise already tight and highly regulated (at the present) MC market depth will fill up with likes of CAN or THC.
I'm a loyal supporter of AC8, they have a huge potential but they also have to realize that they are being outperformed by smaller MC market players and its time to be more proactive moving forward into 2018 (IMO).